Ausgabe 5/1999
Inhalt (7 Artikel)
A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells
Eva Andersson, Paula Henderikx, Elias Krambovitis, Hennie R. Hoogenboom, Carl A. K. Borrebaeck
Adoptive-transfer therapy of tumors with the tumor-specific primary cytotoxic T cells induced in vitro with the B7.1-transduced MCA205 cell line
Sun Jung Kim, Michel Sadelain, Jeong-Soon Lee, Roh Hyun Seong, Yeon-Sook Yun, Young Ju Jang, Hee Young Chung
Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2
Alex B. Lentsch, Frederick N. Miller, Michael J. Edwards
In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors
Michael D'Angelica, Howard Karpoff, Marc Halterman, Jennifer Ellis, David Klimstra, Diane Edelstein, Michael Brownlee, Howard Federoff, Yuman Fong
Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads
Claudia Petrarca, Beniamino Casalino, Silvia von Mensdorff-Pouilly, Aurelia Rughetti, Hassan Rahimi, Giovanni Scambia, Joseph Hilgers, Luigi Frati, Marianna Nuti
Organ-specific pancreatic tumor growth properties and tumor immunity
Keita Morikane, Richard M. Tempero, Connie L. Sivinski, Mitsuharu Nomoto, Michelle L. Van Lith, Tetsuichiro Muto, Michael A. Hollingsworth
Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes
Nicole M. Haynes, Mark J. Smyth, Michael H. Kershaw, Joseph A. Trapani, Phillip K. Darcy